 |
The Journal of Neuroscience, May 5, 2004, 24(18):4333-4339; doi:10.1523/JNEUROSCI.5276-03.2004
Previous Article | Next Article 
Development/Plasticity/Repair
CD4-Positive T Cell-Mediated Neuroprotection Requires Dual Compartment Antigen Presentation
Susanna C. Byram,1,2
Monica J. Carson,3
Cynthia A. DeBoy,1,2
Craig J. Serpe,2
Virginia M. Sanders,4 and
Kathryn J. Jones1,2
1Department of Cell Biology, Neurobiology, and Anatomy, Loyola University Chicago, Maywood, Illinois 60153, 2Research and Development Service, Hines Veterans Affairs Hospital, Hines, Illinois 60141, 3Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, and 4Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210
Our laboratory discovered that CD4-positive (CD4+) T cells of the immune system convey transitory neuroprotection to injured mouse facial motoneurons (FMNs) (Serpe et al., 1999, 2000, 2003). A fundamental question in the mechanisms responsible for neuroprotection concerns the identity of the cell(s) that serves as the antigen-presenting cell (APC) to activate the CD4+ T cells. Here, we first establish that CD4+ T cells reactive to non-CNS antigen fail to support FMN survival and, second, demonstrate a two-compartment model of CD4+ T cell activation. Mouse bone marrow (BM) chimeras were developed that discriminate between resident antigen-presenting host cell and BM-derived antigen-presenting donor cell expression of major histocompatibility complex II within central and peripheral compartments, respectively. After facial nerve transection, neither compartment alone is sufficient to result in activated CD4+ T cell-mediated FMN survival. Rather, CD4+ T cell-mediated neuroprotection appears to depend on both resident microglial cells in the central compartment and a BM-derived APC in the peripheral compartment. This is the first in vivo report demonstrating a neuroprotective mechanism requiring APC functions by resident (i.e., parenchymal) microglial cells.
Key words: microglia; chimera mice; antigen-presenting cell; motoneuron survival; CD4+ T lymphocytes; neuro-immune interactions; facial motoneuron
Received Nov 29, 2003;
revised March 23, 2004;
accepted March 24, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
G. Gowing, T. Philips, B. Van Wijmeersch, J.-N. Audet, M. Dewil, L. Van Den Bosch, A. D. Billiau, W. Robberecht, and J.-P. Julien
Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase
J. Neurosci.,
October 8, 2008;
28(41):
10234 - 10244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Beers, J. S. Henkel, W. Zhao, J. Wang, and S. H. Appel
CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
PNAS,
October 7, 2008;
105(40):
15558 - 15563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Beers, J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis
PNAS,
October 24, 2006;
103(43):
16021 - 16026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Ip, A. Kroner, M. Bendszus, C. Leder, I. Kobsar, S. Fischer, H. Wiendl, K.-A. Nave, and R. Martini
Immune Cells Contribute to Myelin Degeneration and Axonopathic Changes in Mice Overexpressing Proteolipid Protein in Oligodendrocytes
J. Neurosci.,
August 2, 2006;
26(31):
8206 - 8216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ling, M. Sandor, M. Suresh, and Z. Fabry
Traumatic Injury and the Presence of Antigen Differentially Contribute to T-Cell Recruitment in the CNS
J. Neurosci.,
January 18, 2006;
26(3):
731 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Huppenbauer, L. Tanzer, L. L. DonCarlos, and K. J. Jones
Gonadal Steroid Attenuation of Developing Hamster Facial Motoneuron Loss by Axotomy: Equal Efficacy of Testosterone, Dihydrotestosterone, and 17-{beta} Estradiol
J. Neurosci.,
April 20, 2005;
25(16):
4004 - 4013.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|